fenperoximate
Small moleculeexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Nov 9, 2015 (NCT02533336)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fenperoximate
- fenpyroximate
- fenpyroximate
- fenpyroximate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02533336 | Phase 3 | Nov 9, 2015 | Brandeis University, Centers for Disease Control and Prevention (CDC), Kilimanjaro Christian Medical College, Tanzania, National Institute for Medical Research, Tanzania, United States Agency for International Development, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Brandeis University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Centers for Disease Control and Prevention (CDC) | Government | 1 | 0 | 1 | 2015 |
| Kilimanjaro Christian Medical College, Tanzania | Academic/Hospital | 1 | 0 | 1 | 2015 |
| National Institute for Medical Research, Tanzania | Government | 1 | 1 | 1 | 2015 |
| United States Agency for International Development | Government | 1 | 0 | 1 | 2015 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2015 |
6 organizations
Page 1 / 1